Technology

Also, Gold Coast Health has established direct messaging with Rheumatology services.  

HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.

The guidance aims to help countries move toward healthcare digitization through a person-centered point of service system.

Adam Hutchinson, oVRcome founder and CEO, discusses reducing phobias using VR exposure therapy, how the company fills the gap in VR psychiatric care access for providers and patients, and its trial on combatting social anxiety with VR.

The behavioral health company's Engage platform will be available to existing commercial fully insured, self-funded members on an opt-in basis and via Sentara's Marketplace membership.

The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.

The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.

The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.

The funding will support clinical trials for the company's NeuroHawk brain-scanning device.  

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.